Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06739057Completed

Pediatric Ventricle Function Assessment Study

Role: lead

NCT06664554Completed

Predictive Value of Maternal Blood Protein Signatures in Preterm Birth

Role: lead

NCT05131282Completed

Maternal Serum Markers Predicting Preeclampsia At Early Gestations

Role: lead

NCT05108415Unknown

Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

Role: lead

NCT05091229Unknown

A Blood Test to Diagnose Kawasaki Disease

Role: lead

NCT05115786Unknown

Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer

Role: lead

All 6 trials loaded